Type III hypersensitivity reactions to a B cell epitope antigen are abrogated using a depot forming vaccine platform by Lisa D. MacDonald, Alecia MacKay, Valarmathy Kaliaperumal, Genevieve Weir, Andrea Penwell, Rajkannan Rajagopalan, Joanne M. Langley, Scott Halperin, Marc Mansour, Marianne M. Stanford

Get full text